130 related articles for article (PubMed ID: 25651251)
1. Preventing HIV in women--still trying to find their VOICE.
Saag MS
N Engl J Med; 2015 Feb; 372(6):564-6. PubMed ID: 25651251
[No Abstract] [Full Text] [Related]
2. Study halted: no benefit seen from antiretroviral pill in preventing HIV in women.
Stephenson J
JAMA; 2011 May; 305(19):1952. PubMed ID: 21586708
[No Abstract] [Full Text] [Related]
3. VOICE reveals the need to improve adherence in PrEP trials.
Tobin SC
AIDS; 2015 Jul; 29(12):N9. PubMed ID: 26244400
[No Abstract] [Full Text] [Related]
4. Tenofovir-based preexposure prophylaxis for HIV infection among African women.
Marrazzo JM; Ramjee G; Richardson BA; Gomez K; Mgodi N; Nair G; Palanee T; Nakabiito C; van der Straten A; Noguchi L; Hendrix CW; Dai JY; Ganesh S; Mkhize B; Taljaard M; Parikh UM; Piper J; Mâsse B; Grossman C; Rooney J; Schwartz JL; Watts H; Marzinke MA; Hillier SL; McGowan IM; Chirenje ZM;
N Engl J Med; 2015 Feb; 372(6):509-18. PubMed ID: 25651245
[TBL] [Abstract][Full Text] [Related]
5. Pre-exposure prophylaxis in women fails to prevent HIV infection in African study.
Mayor S
BMJ; 2015 Feb; 350():h717. PubMed ID: 25663035
[No Abstract] [Full Text] [Related]
6. Preexposure prophylaxis for HIV infection.
Siemieniuk RA; Bogoch II
N Engl J Med; 2015 Apr; 372(18):1767-8. PubMed ID: 25923561
[No Abstract] [Full Text] [Related]
7. Antiretroviral prophylaxis: a defining moment in HIV control.
Karim SS; Karim QA
Lancet; 2011 Dec; 378(9809):e23-5. PubMed ID: 21771566
[No Abstract] [Full Text] [Related]
8. FDA paves the way for pre-exposure HIV prophylaxis.
Holmes D
Lancet; 2012 Jul; 380(9839):325. PubMed ID: 22852138
[No Abstract] [Full Text] [Related]
9. [Pre-exposure prophylaxis for HIV transmission? No, unless].
Boeke AJ; Heijnen AM
Ned Tijdschr Geneeskd; 2013; 157(27):A6359. PubMed ID: 23838404
[TBL] [Abstract][Full Text] [Related]
10. Drug concentrations after topical and oral antiretroviral pre-exposure prophylaxis: implications for HIV prevention in women.
Karim SS; Kashuba AD; Werner L; Karim QA
Lancet; 2011 Jul; 378(9787):279-81. PubMed ID: 21763939
[No Abstract] [Full Text] [Related]
11. Perceptions of emtricitabine-tenofovir in HIV PrEP.
Kruse L; Stover K; Henderson H
HIV Clin; 2014; 26(1):1, 4-7. PubMed ID: 24855688
[No Abstract] [Full Text] [Related]
12. Preexposure prophylaxis for HIV--where do we go from here?
Cohen MS; Baden LR
N Engl J Med; 2012 Aug; 367(5):459-61. PubMed ID: 22784041
[No Abstract] [Full Text] [Related]
13. The price of tenofovir-emtricitabine undermines the cost-effectiveness and advancement of pre-exposure prophylaxis.
Keller SB; Smith DM
AIDS; 2011 Nov; 25(18):2308-10. PubMed ID: 22067201
[No Abstract] [Full Text] [Related]
14. The introduction of new antiretroviral-based HIV prevention methods into health systems: an update.
Daly F
Reprod Health Matters; 2012 Jun; 20(39):215. PubMed ID: 22789099
[No Abstract] [Full Text] [Related]
15. HIV preexposure prophylaxis: new data and potential use.
Celum CL
Top Antivir Med; 2011 Dec; 19(5):181-5. PubMed ID: 22298887
[TBL] [Abstract][Full Text] [Related]
16. Antiretroviral Pre-Exposure Prophylaxis Does Not Enhance Immune Responses to HIV in Exposed but Uninfected Persons.
Pattacini L; Murnane PM; Baeten JM; Fluharty TR; Thomas KK; Bukusi E; Katabira E; Mugo N; Donnell D; Lingappa JR; Celum C; Marzinke M; McElrath MJ; Lund JM;
J Infect Dis; 2015 Jun; 211(12):1943-52. PubMed ID: 25520426
[TBL] [Abstract][Full Text] [Related]
17. Pre-exposure prophylaxis works--it's time to deliver.
Beyrer C; Bekker LG; Pozniak A; Barré-Sinoussi F
Lancet; 2015 Apr; 385(9977):1482-4. PubMed ID: 25933264
[No Abstract] [Full Text] [Related]
18. When is good good enough for HIV-1 prophylaxis?
Buchbinder S
Lancet Infect Dis; 2014 Nov; 14(11):1024-1025. PubMed ID: 25300861
[No Abstract] [Full Text] [Related]
19. Impact of switching virologically suppressed, HIV-1-infected patients from twice-daily fixed-dose zidovudine/lamivudine to once-daily fixed-dose tenofovir disoproxil fumarate/emtricitabine.
DeJesus E; Ruane P; McDonald C; Garcia F; Sharma S; Corales R; Ravishankar J; Khanlou H; Shamblaw D; Ecker J; Ebrahimi R; Flaherty J;
HIV Clin Trials; 2008; 9(2):103-14. PubMed ID: 18474495
[TBL] [Abstract][Full Text] [Related]
20. Integrating HIV prevention into practice.
Mathers BM; Cooper DA
JAMA; 2014 Jul 23-30; 312(4):349-50. PubMed ID: 25038352
[No Abstract] [Full Text] [Related]
[Next] [New Search]
